Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research interests include Cancer research, Medicine, DNA methylation, Gene silencing, Methylation, and Afatinib.
Effects of KEAP1 Silencing on NRF2 and NOTCH Pathways in SCLC Cell Lines
Clinical and molecular description of the first Italian cohort of 33 subjects with hypophosphatasia
Design and experimental validation of OPERA_MET-A panel for deep methylation analysis by next generation sequencing
Therapeutic Potential of Afatinib in<i>NRG1</i>Fusion-Driven Solid Tumors: A Case Series
Potential Prognostic Role of SPARC Methylation in Non-Small-Cell Lung Cancer
Results from Phase I Clinical Trial with Intraspinal Injection of Neural Stem Cells in Amyotrophic Lateral Sclerosis: A Long-Term Outcome
Methylation Density Pattern of KEAP1 Gene in Lung Cancer Cell Lines Detected by Quantitative Methylation Specific PCR and Pyrosequencing
Effects of KEAP1 Silencing on the Regulation of NRF2 Activity in Neuroendocrine Lung Tumors
Automated Workflow for Somatic and Germline Next Generation Sequencing Analysis in Routine Clinical Cancer Diagnostics
Afatinib as a novel potential treatment option for <i>NRG1</i> fusion-positive tumors.
Targeting NRG1-fusions in multiple tumour types: Afatinib as a novel potential treatment option
NRG1-fusion-driven solid tumours: A case series indicating the therapeutic potential of afatinib
P2.14-32 Epigenetic Silencing of SPARC in NSCLCs
Keap1/Nrf2 pathway in kidney cancer: frequent methylation of KEAP1 gene promoter in clear renal cell carcinoma
Abstract 2397: Epigenetic silencing in clear renal cell carcinoma: <i>KEAP1</i> promoter hypermethylation
Human neural stem cell transplantation in ALS: initial results from a phase I trial
FOSL1 as a candidate target gene for 11q12 rearrangements in desmoplastic fibroblastoma